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The classic phrase to describe cell culture is “every cell line is different.”  The unfortunate part of this idiom is the 
actual concealment of a crucial lack of fundamental understanding.  Furthermore the phrase ignores the 
substantial success achieved to date in developing robust industrial cell culture platforms that are applied to all 
cell lines regardless of their intrinsic variation.  At Biogen, our cell culture medium platform is agnostic to CHO 
host cell line, and the platform can accommodate this inherent genomic variation as cell lines come from 
different host backgrounds.  This is also an opportunity for -omics work then as the differences in cell line 
performance can be linked back to fundamental differences within those host cell lines. However, the power of -
omics technologies to influence process optimization is limited by the difficulty and time scale for execution and 
interpreting such studies. 
   
Our approach to -omics implementation has been to utilize multiple targeted investigations and combine the 
learnings into an implementation strategy focused on enhancing the efficiency of manufacturing.  Metabolic flux 
analysis was used to establish a baseline knowledge of central metabolism in the Biogen platform. The next 
step was to incorporate transcriptomics and proteomics with our metabolomics knowledge.  With Biogen’s 
toolbox of CHO host cell lines, this approach identified intrinsic host cell line differences as well as unique 
limitations in cell culture.  Specifically, we have determined sources of novel metabolic inhibitors that suppress 
cell growth as well as differences in lactate and ammonium metabolism that split according to host cell source.  
These conclusions ultimately lead to the optimized platform process yielding the desired product quality.  
Determining these differences led to an increased growth rate in scale up for cell lines from a more sensitive 
host as well as maintaining robust cell growth and productivity in production bioreactors.  Ultimately still “every 
cell line is different.”  Yet the more we know, the more opportunities there are to exploit both the similarities and 
the differences. 
 
